CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong · Delayed Price · Currency is HKD 2.650
+0.050 (1.92%)
Apr 17, 2026, 4:08 PM HKT
CANbridge Pharmaceuticals Employees
CANbridge Pharmaceuticals had 41 employees as of December 31, 2025. The number of employees decreased by 26 or -38.81% compared to the previous year.
Employees
41
Change (1Y)
-26
Growth (1Y)
-38.81%
Revenue / Employee
1.36M HKD
Profits / Employee
402.19K HKD
Market Cap
1.55B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 41 | -26 | -38.81% |
| Dec 31, 2024 | 67 | -33 | -33.00% |
| Dec 31, 2023 | 100 | -17 | -14.53% |
| Dec 31, 2022 | 117 | -66 | -36.07% |
| Dec 31, 2021 | 183 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1,794 |
| Frontage Holdings | 1,523 |
| Mabpharm | 389 |
| Cutia Therapeutics | 304 |
| Zhaoke Ophthalmology | 276 |
| Immunotech Biopharm | 183 |
| Transcenta Holding | 171 |
| Beijing Biostar Pharmaceuticals | 131 |
CANbridge Pharmaceuticals News
- 8 months ago - China's Push To Expand Access To Costly Therapies And A Partnership Deal Boost Rare Drugs Maker - But Is It Enough? - Benzinga